Frailty in End Stage Renal Disease: Current Perspectives

Overview

Journal Nefrologia (Engl Ed)

Date 2023 Feb 15

PMID 36792307

Authors

Shankar Prasad Nagaraju

Srinivas Vinayak Shenoy

Ankur Gupta

Affiliations

Soon will be listed here.

Abstract

Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD. The pathogenesis of frailty in ESRD is multifactorial including uraemia and dialysis related factors. In this current review, we discuss the importance of frailty, its pathogenesis, screening methods, prognostic implications and management strategies in context of ESRD.

Citing Articles

The Impact of Frailty and Severe Cognitive Impairment on Survival Time and Time to Initiate Dialysis in Older Adults With Advanced Chronic Kidney Disease: A Prospective Observational Cohort Study.

Hussien H, Siriteanu L, Nistor I, Kanbay M, Covic A, Voroneanu L Cureus. 2024; 16(7):e64303.

PMID: 39130911 PMC: 11316242. DOI: 10.7759/cureus.64303.

Correlation analysis between left ventricular global longitudinal strain and major adverse cardiovascular event occurrence in patients with end-stage renal disease.

Xie J, Long X, Xie J, Yang D, Yang J, Mao X Int Urol Nephrol. 2024; 56(9):3031-3037.

PMID: 38630429 DOI: 10.1007/s11255-024-04046-0.

Risk factors for short-term all-cause mortality in patients with end stage renal disease: a scoping review.

Yip W, Ng S, Kaur P, George P, Guan J, Lee G BMC Nephrol. 2024; 25(1):71.

PMID: 38413903 PMC: 10900550. DOI: 10.1186/s12882-024-03503-3.